Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
Launched by MOUNTAIN HOME RESEARCH & EDUCATION CORPORATION · Jan 16, 2024
Trial Information
Current as of May 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective a new digital app for vestibular rehabilitation is for adults who experience dizziness after a mild traumatic brain injury (mTBI). The main goal is to see if using the app helps people improve more than those who follow a standard home exercise program. Both groups will do a series of exercises designed to help with balance and stability over a four-week period, guided by a physical therapist. Participants will be tested before starting and after completing the program to measure their progress.
To be eligible for this trial, participants must be at least 18 years old and have been diagnosed with mTBI and dizziness. They should have a specific level of dizziness or balance issues to qualify. People with severe neurological or cognitive problems, significant mobility issues, or certain vision impairments won't be able to participate. Throughout the trial, participants can expect to complete exercises at home and take part in assessments to track their improvement. It's a helpful opportunity for those struggling with dizziness to explore a new treatment option.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age,
- • diagnosis of mTBI,
- • documented dizziness (total DHI score ≥ 16) and/or imbalance (total functional gait assessment score \< 23/30 or \< age-referenced norms)
- Exclusion Criteria:
- • severe neurological disease (e.g., Parkinson's disease, neuropathy),
- • moderate to severe cognitive impairment (\< 23/30 on the Montreal Cognitive Assessment),
- • significant orthopedic issues that would impact mobility or ability to perform gaze stabilization exercises (e.g., significant cervical dysfunction or pain),
- • vision impairment (best-corrected visual acuity worse than 20/40 in the better eye), and
- • severe depression/anxiety (≥ 9 on the 4-item Patient health Questionnaire)
About Mountain Home Research & Education Corporation
Mountain Home Research & Education Corporation is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes across diverse therapeutic areas. With a commitment to innovation and integrity, the organization collaborates with healthcare professionals and research institutions to conduct rigorous, ethically sound clinical studies. Mountain Home Research & Education Corporation prioritizes the safety and well-being of participants while striving to deliver valuable insights that contribute to the development of effective treatments and healthcare solutions. Their mission embodies a passion for enhancing medical knowledge and fostering progress in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported